Interleukin-18 Is a Prognostic Biomarker Correlated with CD8+ T Cell and Natural Killer Cell Infiltration in Skin Cutaneous Melanoma
Open Access
- 15 November 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (11) , 1993
Abstract
Interleukin-18 (IL-18) is a cytokine that enhances innate and adaptive immune responses. Although there are conflicting reports about the roles of IL-18 in melanoma progression, the clinical relevance of IL-18 expression has not been comprehensively studied. In this study, we investigated IL-18 expression and its correlation with patient survival and immune cell infiltration in melanoma using cancer gene expression data publicly available through various databases. IL18 mRNA expression was found to be significantly lower in melanoma tissues than normal tissues. Kaplan–Meier survival analysis showed that IL18 expression was positively correlated with patient survival. To investigate the possible mechanisms by which IL18 expression increased patient survival, we then assessed the correlation between IL18 expression and immune cell infiltration levels. Infiltration of various immune cells, especially CD8+ T and natural killer (NK) cells, which are cytolytic effector cells, was significantly increased by IL18 expression. Additionally, the expression levels of two cytolytic molecules including perforin and granzyme B were significantly positively correlated with IL18 expression. Collectively, this study provides the first evidence that IL18 expression has prognostic value for melanoma patient survival and is strongly correlated with CD8+ T and NK cell infiltration, suggesting the role of IL-18 as a biomarker for predicting melanoma prognosis.Keywords
Funding Information
- National Research Foundation of Korea (2017R1D1A1B03036390, 2017R1D1A1A02018653)
This publication has 73 references indexed in Scilit:
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival AnalysisPLOS ONE, 2013
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumorsJournal of Experimental Medicine, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- IL-18 Induces PD-1–Dependent Immunosuppression in CancerCancer Research, 2011
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18RαGene Therapy, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- GENT: Gene Expression Database of Normal and Tumor TissuesCancer Informatics, 2011
- Cytotoxic T CellsJournal of Investigative Dermatology, 2006
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Apoptosis and melanoma chemoresistanceOncogene, 2003